European Patent Prosecution

Companies pursuing European patent protection have two primary routes — direct European Patent application and the PCT Euro-PCT route — with timing, cost, and prosecution strategy implications for each: EUROPEAN PATENT CONVENTION (EPC) OVERVIEW: the EPO (European Patent Office) is not an EU institution — it is an intergovernmental organization with 39 contracting states including non-EU countries (Switzerland; Norway; Turkey; UK post-Brexit); a granted European Patent (EP) becomes a bundle of national patents validated in selected member states; DIRECT EP FILING (EP APPLICATION): file EP application directly at EPO; filing fee + search fee + examination fee required; RPO (reduced prior art examination) first if direct EP; designation of all EPC states is automatic (no per-state designation fee); EURO-PCT ROUTE (MOST COMMON FOR INTERNATIONAL APPLICANTS): file PCT application (international phase: typically 18 months); enter European regional phase by month 31 from priority date; pays EPO as ISA (International Searching Authority) or IPEA (International Preliminary Examining Authority); PCT search report and written opinion can be used to expedite EPO examination; STRATEGIC COMPARISON: direct EP filing: faster to grant (if no PCT); lower initial cost if only targeting Europe; must file within 12 months of priority; Euro-PCT: flexibility to delay EP costs to month 31 (while also preserving most other countries via PCT); most large company filings use PCT for multi-country strategy; US companies typically use: US provisional → US non-provisional with PCT claiming priority → enter EPO Euro-PCT at month 31; KEY COST MILESTONES: EPO filing + search fee: ~€1,310 (2024); EPO examination fee: ~€1,930; EPO grant fee + printing: ~€1,080 + page fees; VALIDATION FEES: paid to each national patent office in validated states; typical validation bundle (Germany; France; UK; Netherlands; Spain; Italy): €3,000-6,000 additional; annual renewal fees start from 3rd year from filing: cumulative over 20 years, total EPO prosecution cost including validation for major states: €30,000-70,000; with Unitary Patent: validation in up to 18 states via single fee (€2,000 annually).

EPO examination follows a structured procedure under the European Patent Convention and the Guidelines for Examination — the EPO's approach to novelty and inventive step differs meaningfully from the USPTO and requires specific prosecution strategies: EPO EXAMINATION PROCEDURE: SEARCH PHASE: EPO examiner performs extended European search (EES); issues European Search Report (ESR) + Search Opinion; search opinion identifies anticipated and obvious claims; applicant has 6 months to respond to search opinion; EXAMINATION PHASE: substantive examination begins after applicant requests examination and pays fee; examiner issues Official Action (OA) citing additional prior art or maintaining search opinion objections; response period: 4 months (extendable to 6 months on request; fee required); NOVELTY UNDER EPC ARTICLE 54: prior art = 'everything made available to the public' before filing date; includes global prior art (not US-only) — publications; use; oral disclosure; internet; EPO STRICTNESS: EPO applies strict novelty standard — a document anticipates a claim only if it discloses EVERY feature of the claim either explicitly or implicitly; unlike US doctrine of inherency (which is broad), EPO implicit disclosure is narrow: only what is 'directly and unambiguously derivable' from the document; CLAIM DISTINCTION: distinguish claim from cited document by adding one or more features not found in the document; EPO does not require the distinguishing feature to solve a technical problem (that is the inventive step analysis); INVENTIVE STEP UNDER EPC ARTICLE 56 — PROBLEM-SOLUTION APPROACH: EPO uses the 'problem-solution approach' (PSA) — a structured framework different from KSR: step 1 — CLOSEST PRIOR ART (CPA): select the prior art document that is 'most promising starting point' for arriving at the claimed invention; step 2 — DIFFERENCE: identify differences between the claim and CPA; step 3 — OBJECTIVE TECHNICAL PROBLEM (OTP): formulate the objective technical problem that the distinguishing features solve (must be realistic; cannot overclaim the effect); step 4 — OBVIOUS: would a POSITA, starting from CPA and seeking to solve the OTP, arrive at the claimed invention in an obvious way?; COULD + WOULD: EPO requires showing the POSITA 'WOULD' (not just 'COULD') have made the combination — there must be a reason/motivation beyond mere capability; PROSECUTION STRATEGIES FOR INVENTIVE STEP: provide experimental data showing unexpected technical effect; argue the objective technical problem was not recognized in the prior art; distinguish on the basis of a different selection that produces a non-obvious synergistic effect; claim auxiliaries covering different aspects of the invention if main claim rejected.

EPO divisional applications allow applicants to split their application into multiple co-pending applications — a powerful tool for managing portfolio depth, claim scope, and prosecution history — but with specific European rules that differ significantly from USPTO continuation practice: EPO DIVISIONAL APPLICATIONS — BASICS: Rule 36 EPC: divisional application must be filed from a pending European patent application (parent); TIMING DEADLINE: two options: (1) voluntary division — applicant can file divisional at any time while parent application is 'pending' (including during opposition); (2) in response to non-unity objection (unity of invention requirement under EPC Article 82) — examiner may require restriction to one invention; divisional application must be filed before parent application is GRANTED or REFUSED; once parent is granted or finally refused, no more divisionals; DIVISIONAL FEE STRUCTURE: EPO charges a 'divisional surcharge' for divisional applications filed: in 2nd year from pending: €210; 3rd year: €420; 4th year: €840; 5th year: €1,680; 6th+ year: €2,500; designed to discourage strategic late-stage divisional filing; DIVISIONAL STRATEGY: MULTIPLE INVENTION ASPECTS: file a broad parent covering multiple aspects; prosecute parent to allowance on one aspect; file divisionals for other aspects before parent is granted; divisionals can independently pursue broader or narrower claim scope; CONTINUATION-IN-PART LIMITATION: EPC does not allow true CIP (continuation-in-part) — a European application cannot add new matter that was not in the original priority application; all claims must be supported by the original disclosure; COMPARING TO US CONTINUATIONS: US: can file continuation (same disclosure) or CIP (new matter) at any time before patent issues; can file within narrow window after grant (reissue); EPO: divisionals only while parent pending; no new matter; no reissue equivalent; US COMPANIES USING EPO DIVISIONALS: file broad US parent with PCT; enter EPO Euro-PCT with broad independent claims; let EPO search find prior art; file divisionals on promising claim scopes before parent is granted; coordinate EPO prosecution with US continuation prosecution; DIVISIONAL AND US CONTINUATION COORDINATION: use EPO divisional prosecution to understand European prior art landscape; import successful EPO claim amendments into US continuation strategy; use EPO examination outcome as signal for US patentability.

The Unitary Patent and Unified Patent Court (UPC), which launched June 1, 2023 after decades of negotiations, fundamentally changes European patent strategy by creating a pan-European patent right and a centralized patent court — with significant implications for prosecution and post-grant strategy: UNITARY PATENT — WHAT IT IS: a European Patent (granted by EPO in the normal way) can be registered as a Unitary Patent within one month of grant; COVERAGE: automatically covers all UPC participating member states in a single registration; as of 2024: 17 EU member states (Germany; France; Italy; Netherlands; Austria; Belgium; Bulgaria; Denmark; Estonia; Finland; Latvia; Lithuania; Luxembourg; Malta; Portugal; Romania; Slovenia; Sweden); UK, Poland, and Spain are NOT participating; COST COMPARISON: traditional EP bundle patent validation: registering in DE + FR + NL + IT + ES + UK individually: €5,000-10,000 in translation and validation fees; annual renewal: €3,000-8,000/year cumulative; Unitary Patent: single renewal fee of €2,000/year (covers all 17 participating states simultaneously); TRANSLATION: transitional period: must provide English translation of the full text into any official EU language; once machine translation quality threshold met, translation requirement may be waived; IMPACT ON PROSECUTION STRATEGY: CLAIM DRAFTING: claims drafted for EPO prosecution are valid for both Unitary Patent and traditional EP bundle; no change to prosecution process itself; the unitary patent is granted at the same stage as a traditional EP grant; CLAIM SCOPE: EPO prosecution requirements (unity; clarity; added matter; novelty; inventive step) are identical whether pursuing unitary or bundle; decision between unitary vs. bundle is POST-GRANT; UPC IMPLICATIONS: UPC has jurisdiction over Unitary Patents automatically; UPC also has jurisdiction over traditional EP bundle patents UNLESS opted out; OPT-OUT: existing EP bundle patents can be opted out of UPC jurisdiction for 7 years (transitional period) by registering the opt-out in the UPC's Case Management System (CMS); STRATEGIC CONSIDERATIONS: (1) UNITARY PATENT = UPC JURISDICTION AUTOMATICALLY: pan-European injunction possible from single UPC action — high value for patent holders; but also vulnerable to pan-European revocation from a single UPC central division action; (2) OPT-OUT FOR BUNDLE PATENTS: for valuable granted EP bundle patents, filing an opt-out preserves right to enforce in national courts (not UPC) and protects against pan-European revocation; (3) REVOCATION RISK: UPC central revocation: one successful challenge can invalidate the patent in all UPC states simultaneously — more dangerous than EPO opposition for very valuable patents; LICENSING IMPLICATIONS: licensing a Unitary Patent licenses all covered states simultaneously; useful for broad FRAND licensing programs; Avanci and other pools already integrating unitary patents.